Milton J. Zmijewski
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Enzyme Catalysis and Immobilization, Microbial Metabolic Engineering and Bioproduction, Carbohydrate Chemistry and Synthesis, Chemical Synthesis and Analysis
Most-Cited Works
- → Application of a Practical Biocatalytic Reduction to an Enantioselective Synthesis of the 5H-2,3-Benzodiazepine LY300164(1995)107 cited
- → Large-scale stereoselective enzymatic ketone reduction with in situ product removal via polymeric adsorbent resins(1997)103 cited
- → Enantioselective acylation of a beta-lactam intermediate in the synthesis of loracarbef using penicillin G amidase(1991)80 cited
- → Pyrrolo(1,4)benzodiazepine antitumor antibiotics In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules(1977)64 cited
- Enzyme technologies for pharmaceutical and biotechnological applications(2001)
- → Synthesis and biological activity of some known and putative duloxetine metabolites(2004)43 cited
- → Biosynthesis of the antitumor antibiotic naphthyridinomycin(1982)37 cited
- → Biosynthesis of anthramycin. Determination of the labeling pattern by the use of radioactive and stable isotope techniques(1975)36 cited
- → Purification, characterization, cDNA cloning and expression of a novel ketoreductase from Zygosaccharomyces rouxii(2000)31 cited
- → Bioreduction of (R)-carvone and regioselective Baeyer-Villiger oxidations: Application to the asymmetric synthesis of cryptophycin fragment A(1998)30 cited